Results 231 to 240 of about 259,973 (348)

Clinical and Biochemical Factors Associated With Infliximab Pharmacokinetics in Adult Patients With Inflammatory Bowel Disease

The Journal of Clinical Pharmacology, EarlyView.
Abstract Many patients with inflammatory bowel disease (IBD) do not adequately respond to infliximab, potentially due to individual differences in pharmacokinetics (PK). This study aimed to identify clinical and biochemical variables associated with infliximab PK.
Ilse A. Pool, Ilse Volkerink, Mirthe Stavast, Jos G. W. Kosterink, Gerard Dijkstra, Paola Mian, Arno R. Bourgonje   +6 more
wiley   +1 more source

Rectal treatment in ulcerative colitis; a qualitative study exploring reasons for under utilisation. [PDF]

Front Health Serv
Rothen JP, Moerlen F, von Büren C, Allemann S, Arnet I.   +4 more
europepmc   +1 more source

Ulcerative colitis in infancy

, 1964
B. Nicholl
openalex   +1 more source

Early course of ulcerative colitis. [PDF]

, 1966
J. McK. Watts, F T de Dombal, G Watkinson, J C Goligher   +3 more
openalex   +1 more source

Accuracy of Bowel Ultrasound for Detecting Inflammatory Bowel Disease at a Tertiary Hospital in Central South Africa

Journal of Clinical Ultrasound, EarlyView.
Bowel wall thickness, as measured by bowel ultrasound, demonstrates high diagnostic accuracy in evaluating patients with suspected inflammatory bowel disease (IBD). When combined with other bowel ultrasound parameters, this non‐invasive tool can serve as an effective screening method to accelerate IBD diagnosis.
Amanda Hendricks, Henra Muller
wiley   +1 more source

The Use and Role of Mesalamine in the Treatment of Ulcerative Colitis: A Literature Review. [PDF]

Cureus
Chand S, Bendagiri Matam M, Bhatt NK, Neelakantan Ramaswamy S, Harikrishnan S, Agarwal Y, Mohammed L.   +6 more
europepmc   +1 more source

Intestinal Obstruction Following Total Colectomy for Ulcerative Colitis*

, 1961
G. E. Tolstedt, Jonathan Bell
openalex   +2 more sources

Ulcerative Colitis: Advances in Pathogenesis, Biomarkers, and Therapeutic Strategies. [PDF]

Pharmgenomics Pers Med
Bu S, Cheng X, Chen M, Yu Y.
europepmc   +1 more source

Ulcerative Colitis and Scleroderma

, 1965
Vincent A. DeLuca, Howard M. Spiro, Walter R. Thayer   +2 more
openalex   +1 more source

Most costly and prevalent reasons for hospitalization in children with medical complexity in Ontario, Canada

Journal of Hospital Medicine, EarlyView.
Abstract Background and Objectives Children with medical complexity (CMC) have chronic health conditions often associated with functional limitations. CMC comprise 1%–5% of the pediatric population. In Canada, their care accounts for one‐third of pediatric health spending.
Erin Hessey, Thaksha Thavam, Sanjay Mahant, Eyal Cohen, Jingqin Zhu, Francine Buchanan, Teresa To, Peter J. Gill, Ontario Pediatric Hospital Care Study Group (OPHCSG) and the Canadian Paediatric Inpatient Research Network (PIRN), Wenjia Chen, Ronald Cohn, Mairead Green, Matt Hall, Kate Langrish, Colin Macarthur, Myla Moretti, Patricia Parkin, Michelle Quinlan, Ann Bayliss, Ronik Kanani, Sean Murray, Catherine Pound, Mahmoud Sakran, Anupam Sehgal, Sepi Taheri, Gita Wahi   +25 more
wiley   +1 more source